131 related articles for article (PubMed ID: 2199223)
1. Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences.
Hölting T; Schlag P; Georgi P
Eur J Surg Oncol; 1990 Aug; 16(4):312-8. PubMed ID: 2199223
[TBL] [Abstract][Full Text] [Related]
2. The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method.
Hölting T; Schlag P; Steinbächer M; Kretzschmar U; Georgi P; Herfarth C
Cancer; 1989 Aug; 64(4):830-3. PubMed ID: 2743277
[TBL] [Abstract][Full Text] [Related]
3. [Does immunoscintigraphy improve early diagnosis of metastatic or recurrent cancer?].
Hölting T; Steinbächer M; Kretzschmar U; Georgi P; Schlag P
Onkologie; 1989 Aug; 12 Suppl 1():20-5. PubMed ID: 2685691
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
[TBL] [Abstract][Full Text] [Related]
5. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
[TBL] [Abstract][Full Text] [Related]
6. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
[TBL] [Abstract][Full Text] [Related]
8. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods].
Behr TM; Goldenberg DM; Scheele JR; Wolf FG; Becker W
Dtsch Med Wochenschr; 1997 Apr; 122(15):463-70. PubMed ID: 9147937
[TBL] [Abstract][Full Text] [Related]
9. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M
Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454
[TBL] [Abstract][Full Text] [Related]
10. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer].
García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM
Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910
[TBL] [Abstract][Full Text] [Related]
13. [Current role of immunoscintigraphy for surgical therapy of the recurrence of colorectal cancers].
Schlag P; Hölting T; Steinbächer M; Kretzschmar U; Georgi P
Chirurg; 1987 Sep; 58(9):594-6. PubMed ID: 3677890
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.
Bischof-Delaloye A; Delaloye B; Buchegger F; Gilgien W; Studer A; Curchod S; Givel JC; Mosimann F; Pettavel J; Mach JP
J Nucl Med; 1989 Oct; 30(10):1646-56. PubMed ID: 2795205
[TBL] [Abstract][Full Text] [Related]
15. [Clinical application of radioimmunolocalization in colorectal cancer].
Germà JR; Alvarez I; Carrió I; Estorch M; Bernà L; Martínez-Duncker C; Marcuello E; Nogueras FM
Med Clin (Barc); 1990 Mar; 94(9):325-8. PubMed ID: 2329866
[TBL] [Abstract][Full Text] [Related]
16. The value of immunoscintigraphy in the detection of recurrent colorectal cancer.
Baulieu F; Bourlier P; Scotto B; Mor C; Eder V; Picon L; De Calan L; Dorval E; Pottier JM; Baulieu JL
Nucl Med Commun; 2001 Dec; 22(12):1295-304. PubMed ID: 11711899
[TBL] [Abstract][Full Text] [Related]
17. Imaging of pancreatic and colorectal cancer using antibody fragments: a preliminary evaluation.
Ballantyne KC; Perkins AC; Selby C; Wastie ML; Hardcastle JD
Eur J Surg Oncol; 1988 Oct; 14(5):393-8. PubMed ID: 3181442
[TBL] [Abstract][Full Text] [Related]
18. [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study].
Imdahl A; Bräutigam P; Hauenstein KH; Eggstein S; Waninger J; Farthmann EH
Zentralbl Chir; 1994; 119(1):17-22. PubMed ID: 8147155
[TBL] [Abstract][Full Text] [Related]
19. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist].
Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH
Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823
[TBL] [Abstract][Full Text] [Related]
20. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
